Scholarlink

The intention of hepatocellular carcinoma (HCC) surveillance is to detect and treat cancer at early stages which leads to improvement in liver-related survival. Historically, surveillance has been restricted to select patients with well-compensated cirrhosis and decompensated cirrhosis unless candidates for transplant. This chapter reviews the pros and cons of this restriction. Although liver dysfunction can limit HCC treatment and adversely affect overall mortality, there is heterogeneity in prognosis among patients with decompensated cirrhosis. Also, advances in selective delivery of locoregional therapies and systemic therapies may be better tolerated and offer benefit to select patients with CPS class B cirrhosis.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Should Hepatocellular Carcinoma Surveillance Be Performed Only for Patients with Decompensated Cirrhosis If They Are Listed for Liver Transplantation?

  • 章节

  • 发表日期：

    2025年

查看全文
  • Dharani Guttikonda,
  • Sheila Eswaran

摘要

The intention of hepatocellular carcinoma (HCC) surveillance is to detect and treat cancer at early stages which leads to improvement in liver-related survival. Historically, surveillance has been restricted to select patients with well-compensated cirrhosis and decompensated cirrhosis unless candidates for transplant. This chapter reviews the pros and cons of this restriction. Although liver dysfunction can limit HCC treatment and adversely affect overall mortality, there is heterogeneity in prognosis among patients with decompensated cirrhosis. Also, advances in selective delivery of locoregional therapies and systemic therapies may be better tolerated and offer benefit to select patients with CPS class B cirrhosis.